Research map: Golgi Protein 73 and Laminin‐γ2 Monomer‐Based Score for the Diagnosis of Advanced Liver Fibrosis in Patients With Metabolic Dysfunction‐Associated Steatotic Liver Disease

Back to the article

Papers in this map

  1. Design and validation of a histological scoring system for nonalcoholic fatty liver disease† · David Erwin Kleiner · 2005 · 10909 citations · Cited by this paper
  2. Investigating the Association Between Cystic Fibrosis and Colorectal Neoplasia: A Matched Case–Control Study · 2026 · Related
  3. The metabolic syndrome—a new worldwide definition · K. G. M. M. Alberti · 2005 · 9352 citations · Cited by this paper
  4. Rise in Admissions for Acute Severe Ulcerative Colitis at an Australian Health Service With a Culturally and Linguistically Diverse Population · 2026 · Related
  5. A multisociety Delphi consensus statement on new fatty liver disease nomenclature · Mary Eugenia Rinella · 2023 · 3201 citations · Cited by this paper
  6. Gastric Microbiome Alterations in Sepsis‐Related Gastrointestinal Bleeding: Two Case Reports and Literature Review · 2026 · Related
  7. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease · Mary Eugenia Rinella · 2023 · 2555 citations · Cited by this paper
  8. Clinical Utility of the Apolipoprotein A2 Isoform Index as a Tumor Marker for Pancreatic Cancer · 2026 · Related
  9. Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up · Mattias Ekstedt · 2014 · 2304 citations · Cited by this paper
  10. Pediatric Colorectal Cancer in Africa: A Multicenter Study on Epidemiology, Management, and Outcomes Between 2000 and 2023 · 2026 · Related
  11. Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease · Vlad Ratziu · 2005 · 2109 citations · Cited by this paper
  12. The Difference in Clinical Features and Hepatic Injury Characteristics Between Children and Adults With Infectious Mononucleosis · 2026 · Related
  13. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) · Frank Tacke · 2024 · 2049 citations · Cited by this paper
  14. Predictors of True Early Recurrence in Patients Undergoing Radiofrequency Ablation for Hepatocellular Carcinoma · 2026 · Related
  15. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis · 2015 · 1905 citations · Cited by this paper
  16. The Burden of Viral Respiratory Infections in Immunosuppressed Inflammatory Bowel Disease Patients · 2026 · Related
  17. The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology · Naga Chalasani · 2012 · 1788 citations · Cited by this paper
  18. Loss of Response to Anti‐Tumor Necrosis Factor Alpha Therapy in Patients With Inflammatory Bowel Disease: A Real‐World Comparison of Combination Therapy Versus Monotherapy · 2026 · Related
  19. Complications following percutaneous liver biopsy · Felice Piccinino · 1986 · 1213 citations · Cited by this paper
  20. Stricturing Diseases of the Gastrointestinal Tract—Current Clinical Practice · 2026 · Related
  21. Pitfalls of Liver Stiffness Measurement: A 5-Year Prospective Study of 13,369 Examinations · Laurent Castéra · 2009 · 1164 citations · Cited by this paper
  22. Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis · Stuart McPherson · 2016 · 945 citations · Cited by this paper
  23. Epidemiology of metabolic dysfunction-associated steatotic liver disease · Zobair M. Younossi · 2024 · 876 citations · Cited by this paper
  24. Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review · Wah‐Kheong Chan · 2023 · 761 citations · Cited by this paper
  25. Determination of reliability criteria for liver stiffness evaluation by transient elastography · Jérôme Boursier · 2012 · 660 citations · Cited by this paper
  26. EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease · European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO) · 2016 · 528 citations · Cited by this paper
  27. The New BMI Criteria for Asians by the Regional Office for the Western Pacific Region of WHO are Suitable for Screening of Overweight to Prevent Metabolic Syndrome in Elder Japanese Workers · Erdembileg Anuurad · 2003 · 419 citations · Cited by this paper
  28. Localization of proteins to the Golgi apparatus · Sean Munro · 1998 · 266 citations · Cited by this paper
  29. A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis · Chan Wah Kheong · 2017 · 261 citations · Cited by this paper
  30. Non-alcoholic fatty liver disease in 2015 · Monjur Ahmed∥ · 2015 · 176 citations · Cited by this paper
  31. The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease · Mohammed Eslam · 2025 · 168 citations · Cited by this paper
  32. Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis-4 Score, and Liver Stiffness Measurement to Identify Patients With Advanced Fibrosis · Wah‐Kheong Chan · 2019 · 116 citations · Cited by this paper
  33. Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis · Meiyu Dai · 2015 · 65 citations · Cited by this paper
  34. The Clinical Significance of GP73 in Immunologically Mediated Chronic Liver Diseases: Experimental Data and Literature Review · Mingjie Yao · 2017 · 57 citations · Cited by this paper
  35. Serum GP73, a Marker for Evaluating Progression in Patients with Chronic HBV Infections · Hongshan Wei · 2013 · 55 citations · Cited by this paper
  36. Serum Laminin γ2 Monomer as a Diagnostic and Predictive Biomarker for Hepatocellular Carcinoma · Taro Yamashita · 2021 · 48 citations · Cited by this paper
  37. Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction‐associated fatty liver disease · Wah‐Kheong Chan · 2022 · 47 citations · Cited by this paper
  38. Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma · Tianhui Liu · 2017 · 46 citations · Cited by this paper
  39. Combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levels · Kenneth I. Zheng · 2020 · 39 citations · Cited by this paper

Source: OpenAlex (CC0)